Pharma-Bio Serv, Inc. (PBSV) stock
PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
$0.48+0.08 (+20.00%)
Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –
Pharma-Bio Serv revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Pharma-Bio Serv's revenue for the twelve months ending Jul 31, 2026 was $9.48M, up 3.3% year over year. For fiscal 2025 it was $9.00M, down 5.3% from the year before. Over ten years it grew -9.1% a year on average. The highest annual figure on record is $33.06M in fiscal 2013.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $9.00M | -5.3% |
| FY2024 | Oct 31, 2024 | $9.51M | -44.0% |
| FY2023 | Oct 31, 2023 | $16.98M | -12.5% |
| FY2022 | Oct 31, 2022 | $19.40M | -3.6% |
| FY2021 | Oct 31, 2021 | $20.12M | -6.7% |
| FY2020 | Oct 31, 2020 | $21.56M | +10.5% |
| FY2019 | Oct 31, 2019 | $19.51M | +9.6% |
| FY2018 | Oct 31, 2018 | $17.80M | +33.8% |
| FY2017 | Oct 31, 2017 | $13.30M | -31.9% |
| FY2016 | Oct 31, 2016 | $19.54M | -16.5% |
| FY2015 | Oct 31, 2015 | $23.38M | -15.1% |
| FY2014 | Oct 31, 2014 | $27.56M | -16.7% |
| FY2013 | Oct 31, 2013 | $33.06M | +13.1% |
| FY2012 | Oct 31, 2012 | $29.23M | +46.6% |
| FY2011 | Oct 31, 2011 | $19.93M | +75.7% |
| FY2010 | Oct 31, 2010 | $11.35M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $2.34M | +19.0% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $2.70M | +11.8% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $2.29M | -7.1% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $2.15M | -7.9% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $1.96M | -18.8% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $2.42M | +1.7% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $2.47M | +3.8% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $2.33M | -35.2% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $2.42M | -47.2% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $2.38M | -47.9% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $2.38M | -43.8% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $3.60M | -75.6% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $4.58M | -18.2% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $4.56M | -8.5% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | $4.24M | -15.9% |
| Q1 FY2022CQ4 2021 | Jul 31, 2022 | $14.76M | +228.9% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $5.60M | +11.4% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $4.99M | -20.6% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $5.04M | -10.7% |
| Q1 FY2021CQ4 2020 | Jan 31, 2021 | $4.49M | -2.7% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $5.03M | +4.2% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $6.28M | +26.4% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $5.65M | +9.7% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $4.61M | +1.0% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $4.82M | -15.0% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $4.97M | +7.2% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $5.15M | +36.8% |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | $4.57M | +22.5% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $5.67M | +320.3% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $4.63M | +16.4% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $3.77M | -4.0% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $3.73M | -7.9% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $1.35M | -70.9% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $3.98M | -18.2% |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $3.92M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $4.05M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $4.64M | – |
| Q3 FY2016CQ2 2016 | Jul 31, 2016 | $4.87M | – |
See a number that looks wrong?